10.1002/ejoc.201901877
European Journal of Organic Chemistry
FULL PAPER
(43 mg, 0.2 mmol) according to the general procedure A. The crude
product was purified by flash chromatography (PE/EtOAc 95:5) to afford
(Z)-3Aq (10 mg, 0.034 mmol) in 17% yield asa yellow oil, and(E)-3Aq (20
mg, 0.068 mmol) in 34% yield as a yellow oil. (Z)-ethyl 2-methoxy-3-
(pentafluorophenyl)acrylate (Z)-3Aq: IR: 2880, 1705, 1672, 1598, 1322,
1163, 835 cm-1. 19F NMR (282 MHz, CDCl3) δ -136.9 – 136.6 (m, 2F), -
154.4 − -154.5 (t, J = 19.7 Hz, F), -162.4 − -162.5 (m, 2F). 1H NMR (300
MHz, CDCl3) δ 6.60 (bs, 1H), 4.34 (q, J = 7.1 Hz, 2H), 3.81 (s, 3H), 1.39
(t, J = 7.1 Hz, 3H). 13C NMR (75 MHz, CDCl3) δ 162.6 (C), 150.2 (C), 146.3
– 146.0 (m, C), 143.0 – 142.6 (m, C), 139, 6 – 139,0 (m, C), 136.3– 135.9
(m, C), 108.9 (td, JC-F = 4.1 and 18.1 Hz, C), 105.4 (d, JC-F = 4.0 Hz, CH),
62.1 (CH2), 59.5 (CH3), 14.3 (CH3). MS (ESI-TOF) m/z 297.15 [M+H+].
HMRS (ESI-TOF): calc. for C12H10F5O3; 297.1930: found 297.1945. (E)-
ethyl 2-methoxy-3-(pentafluorophenyl)acrylate (E)-3Aq: IR: 2880,
1705, 1672, 1598, 1322, 1163, 835 cm-1. 19F NMR (282 MHz, CDCl3) δ -
139.9 (dd, J = 9.5 and 22.5 Hz, 2F),. -156.5 (t, J = 22.5 Hz, F), -163.3 (dd,
J = 14.1 and 19.7 Hz, 2F). 1H NMR (300 MHz, CDCl3) 5.59 (s, 1H), 4.22
(q, J = 7.1 Hz, 2H), 3.83 (s, 3H), 1.22 (t, J = 7.1 Hz, 3H). 13C NMR (75 MHz,
CDCl3) δ 162.2 (C), 152.8 (C), 146.3 −146.0 (m, C), 143.0 − 142.6(m, C),
139.7 – 139.1 (m, C), 136.3 − 135.9 (m, C), 139.2 − 138.8 (m, C), 135.9 −
135.8 (m, C), 108.9 (td, JC-F = 4.1 and 18.2 Hz), 105.3 (d, JC-F = 2,1 Hz,
CH), 61.9 (CH2), 59.6 (CH3), 14.3 (CH3). HMRS (ESI-TOF): calc. for
C12H10F5O3; 297.1930: found297.1945.
(Z)-benzyl 2-methoxy-3-(2-methoxyphenyl)acrylate 3Ca: Compound
3Ca was prepared from 1C (57 mg,0.3 mmol), and2-methoxybenzoic acid
1a (30 mg, 0.2 mmol) according to the general procedure A. The crude
product was purified by flash chromatography (PE/EtOAc 9:1) to afford
3Ca (30 mg, 0.1 mmol) in 50% yield asa yellow oil.IR: 2992, 2850,1720,
1625, 1580, 11474, 1111, 830, 752 cm-1. 1H NMR (300 MHz, CDCl3) δ
8.10 (dd, J = 1.7 and 7.8 Hz, 1H), 7.51 (s, 1H), 7.47 – 7.27 (m, 5H), 7.01
– 6.94 (m, 1H), 6.88 (dd, J = 1.2and8.3 Hz, 1H), 5.31 (s, 2H), 3.85 (s, 3H),
3.74 (s, 3H). 13C NMR (75 MHz, CDCl3) δ 164.6 (C), 157.5 (C), 145.5 (C),
136.1 (C), 130.7 (CH), 130.4 (CH), 128.7(2xCH), 128.3(2xCH), 122.3(C),
120.7 (CH), 118.0 (CH), 110.5 (CH), 66.8 (CH2), 59.4 (CH3), 55.7 (CH3).
MS (ESI-TOF) m/z 299.15 [M+H+]. HMRS (ESI-TOF): calc. for C18H19O4;
299.3410: found299.3425.
(Z)-ethyl 3-(2-methoxyphenyl)-2-phenoxyacrylate 3Da: Compound
3Da was prepared from 1D (58 mg, 0.300 mmol), and 2-methoxybenzoic
acid 2a (31 mg, 0.2 mmol) according to the general procedure A. The
crude product was purified by flash chromatography (PE/EtOAc 9:1) to
afford 3Da (36 mg, 0.12 mmol) in60%yieldasa yellow oil.IR: 2938, 2845,
1705, 1680, 1450, 1096, 1016,821, 750cm-1. 1H NMR (300 MHz, CDCl3)
δ 7.90 (d, J = 7.7 Hz, 1H), 7.78 (s, 1H), 7.25 – 7.11 (m, 3H), 6.99 − 6.93
(m, 3H), 6.85 – 6.79 (m, 2H), 4.15 (q, J = 7.1 Hz, 2H), 3.84 (s, 3H), 1.14 (t,
J = 7.1 Hz, 3H). 13C NMR (75 MHz, CDCl3) δ 164.0 (C), 157.7 (C), 156.9
(C), 140.0 (C), 130.9 (CH), 130.6 (CH), 129.7 (2xCH), 122.5 (CH), 121.6
(C), 120.9 (CH), 120.7 (CH), 115.7 (2xCH), 110.6 (CH), 61.4 (CH2), 55.7
(CH3), 14.2 (CH3). MS (ESI-TOF) m/z 299.15 [M+H+]. HMRS (ESI-TOF):
calc. for C18H19O4; 299.3380: found299.3395.
(Z)-2-(1,1-dimethylethyl)-5-(2-methoxybenzylidene)-1,3-dioxolan-4-
one 3Ba: Compound 3Ba wasprepared from 1B (47 mg, 0.3 mmol), and
2-methoxybenzoic acid 1a (35 mg, 0.2 mmol) according to the general
procedure A. The crude product was purified by flash chromatography
(PE/EtOAc 9:1)to afford 3Ba (21 mg, 0.08 mmol) in 40% yieldasa yellow
oil. IR: 2964, 1788, 1235, 753 cm-1. 1H NMR (300 MHz, CDCl3) δ 7.88(dd,
J = 1.6 and 7.8 Hz, 1H), 7.24 – 7.17 (m, 1H), 6.94 – 6.86 (m, 2H), 6.82 (d,
J = 8.3 Hz, 1H), 5.51 (s, 1H), 3.78 (s, 3H), 0.96 (s, 9H). 13C NMR (75 MHz,
CDCl3) δ 164.2 (C), 157.4 (C), 136.6 (C), 130.1 (CH), 129.9 (CH), 121.9
(C), 120.7 (CH), 110.6 (CH), 109.2 (CH), 101.7 (CH), 55.6 (CH3), 36.1 (C),
23.0 (3xCH3). MS (ESI-TOF) m/z 263.14 [M+H+]. HMRS (ESI-TOF): calc.
for C15H19O4; 263.3050:found263.3122.
(Z)-ethyl 2-benzyloxy-3-(2-methoxyphenyl)acrylate 3Ea: Compound
3Ea wasprepared from 1E (62 mg, 0.3mmol), and 2-methoxybenzoic acid
1a (31 mg, 0.2 mmol) according to the general procedure A.The crude
product was purified by flash chromatography (PE/EtOAc 9:1) to afford
3Ea (54 mg, 0.172 mmol) in 86% yield as a yellow oil. IR: 2940, 2845,
1710, 1670, 1550, 1100, 1016,821, 750cm-1. 1H NMR (300 MHz, CDCl3)
δ 8.16 (dd, J = 1.9 and 7.8 Hz, 1H), 7.53 (s, 1H), 7.45 – 7.36 (m, 2H), 7.34
– 7.27 (m, 4H), 6.96 – 6.88 (m, 2H), 4.93 (s, 2H), 4.34 (q, J = 7.1 Hz, 2H),
3.87 (s, 3H), 1.13 (t, J = 7.1 Hz, 3H). 13C NMR (75 MHz, CDCl3) δ 164.8
(C), 157.4 (C), 144.4 (C), 137.0 (C), 130.9 (CH), 130.3 (CH), 128.6 (CH),
128.5 (2xCH), 128.4 (CH), 128.1 (CH), 122.3 (C), 120.6 (CH), 118.3 (CH),
110.5 (CH), 73.6 (CH2), 61.2 (CH2), 55.6 (CH3), 14.4 (CH3). MS (ESI-TOF)
m/z 313.15 [M+H+]. HMRS (EI+): calc. for C19H20O4; 312.1361: found
312.1353.
(Z)-2-(1,1-dimethylethyl)-5-(2,6-difluorobenzylidene)-1,3-dioxolan-4-
one 3Br: Compound 3Br was prepared from 1B (47 mg, 0.3 mmol), and
2,6-difluorobenzoic acid 2r (37 mg, 0.2 mmol) in DMF/DMSO instead of
1,4-dioxane/DMSO according to the general procedure A. The crude
product waspurified by flash chromatography (PE/EtOAc 9:1) to afford 3Br
(16 mg, 0.06 mmol) in 30% yield as a yellow oil. IR: 2964, 2850, 1788,
1680, 1235, 852, 753,630 cm-1. 19F NMR (282 MHz, CDCl3) δ -107.3 (t, J
= 7.13 Hz, 2F). 1H NMR (300 MHz, CDCl3) δ 7.31 – 7.23 (m, 1H), 6.92 (t,
J = 8.2 Hz, 2H), 6.40 (s, 1H), 5.55 (s, 1H), 1.02 (s, 9H). 13C NMR (75 MHz,
CDCl3) δ 163.09 (C), 160.7 (dd, JC-F = 7.4 and 251 Hz, 2xC), 139.6 (C),
130.23 (t, JC-F = 10.3 Hz, CH), 111.6 (d, JC-F = 23.4 Hz, CH), 111.5 (d, JC-
F = 23.4 Hz, CH), 111.6 − 111.3 (m, C), 110.5 (CH), 93.7 (t, JC-F = 2.3 Hz,
CH), 36.3 (C), 23.0 (CH3), 22.9 (2xCH3). MS (ESI-TOF) m/z 269.12 [M+H+].
HMRS (ESI-TOF): calc. for C14H15F2O3; 269.2598:found269.2630.
(Z)-benzyl 2-benzyloxy-3-(2,6-difluorophenyl)acrylate 3Er: Compound
3Er was prepared for 1E (62 mg, 0.3 mmol), and2,6-difluorobenzoic acid
2r (37 mg, 0.2 mmol) in DFM/DMSO instead of 1,4-dioxane/DMSO
according to the general procedure A. The crude product waspurified by
flash chromatography (PE/EtOAc 9:1) to afford 3Er (25 mg, 0.08mmol) in
40% yield as a yellow oil. IR: 2850, 1720, 1625, 1590, 1501, 1016, 890,
821, 705 cm-1. 19F NMR (282 MHz, CDCl3) δ -108.2 (t, J = 7.13 Hz, 2F).
1H NMR (300 MHz, CDCl3) δ 7.28 – 7.21 (m, 6H), 6.91 – 6.83 (m, 3H),
4.97 (s, 2H), 4.36 (q, J = 7.2 Hz, 2H), 1.38 (t, J = 7.1 Hz, 3H). 13C NMR (75
MHz, CDCl3) δ 163.4 (C), 160.5 (dd, JC-F = 7.3 and 249.9 Hz, 2C), 147.5
(C), 136.7 (C), 129.8 (t, J = 10.4 Hz, CH), 128.3 (2xCH), 128.2 (2xCH),
128.0 (CH), 111.6-111.3 (m, C), 111.3 (d, JC-F = 23.8 Hz, CH), 111.2 (d,
JC-F = 23.8 Hz, CH), 110.9 (CH), 73.5 (CH2), 61.7 (CH2), 14.3 (CH3). MS
(ESI-TOF) m/z 319.12 [M+H+]. HMRS (ESI-TOF): calc. for C18H17F2O3;
319.3198: found319.3205.
(Z)-benzyl 2-methoxy-3-(2,6-difluorophenyl)acrylate 3Cr: Compound
3Cr was prepared from 1C (57 mg, 0.3 mmol), and 2,6-difluorobenzoic
acid 2r (37 mg, 0.2 mmol) in DMF/DMSO instead of 1,4-dioxane/DMSO
according to the general procedure A. The crude product waspurified by
flash chromatography (PE/EtOAc 95:5) to afford 3Cr (27 mg, 0.09 mmol)
in 46% yield asa yellow oil. IR: 2992, 2850, 1720, 1625, 1590, 1501, 1016,
890, 821, 710cm-1. 19F NMR (282 MHz, CDCl3) δ -108.3 (t, J = 7.1 Hz, 2F).
1H NMR (300 MHz, CDCl3) δ 7.47 – 7.34 (m, 5H), 7.29 – 7.20 (m, 1H),
6.90 (t, J = 8.1 Hz, 2H), 6.84 (s, 1H), 5.31 (s, 2H), 3.77 (s, 3H). 13C NMR
(75 MHz, CDCl3) δ 163.2 (C), 160.6 (dd, JC-F = 7.3 and 249.9 Hz, 2xCH),
148.5 (C), 135.5 (C), 129.9 (t, JC-F = 10.4 Hz, CH), 128.7 (2xCH), 128.5
(CH), 128.4 (2xCH), 111.4 (d, JC-F = 23.7 Hz, CH), 111.3(d, JC-F = 23.8 Hz,
CH), 111.4 – 110.9 (m, C), 109.4 (CH), 67.3 (CH2), 59.5 (CH3) . MS (ESI-
TOF) m/z 305.13 [M+H+]. HMRS (ESI-TOF): calc. for C17H15F2O3;
305.2928: found305.2935.
Diethyl 2,5-dimethoxyhexa-2,4-dienedioate 5: Compound 5 was
obtained as a side product during the Myers coupling in presence of
electron-deficient benzoic acids. Colorless oil. IR: 3453.5, 2986.1, 1718,
1248.4, 1093.6, 857.3cm-1. 1H NMR (300 MHz, CDCl3) δ 7.02 (s, 1H), 4.29
(q, J = 7.1 Hz, 2H), 3.80 (s, 3H), 1.35 (t, J = 7.1 Hz, 3H). 13C NMR (75 MHz,
CDCl3) δ 163.3 (2xC), 148.4 (2xC), 116.7 (2xCH), 61.4 (2xCH2), 60.7
(2xCH3), 14.4 (2xCH3). MS (ESI-TOF) m/z 259.15 [M+H+]. HMRS (ESI-
TOF): calc. for C12H19O6; 259.2701: found259.2720.
8
This article is protected by copyright. All rights reserved.